Immune cells specialize to ensure the most efficient defense against viruses and other pathogens. Researchers at the University of Basel have shed light on this specialization of T cells and shown that it occurs differently in the context of an…
Read More
New 3-D printed hydrogels for T-cell growth for cancer immunotherapy
A team with the participation of researchers from the ICMAB has designed new hydrogels for culturing T-cells or T-lymphocytes, cells of the immune system that are used in cancer immunotherapy with the capacity to destroy tumor cells. These hydrogels can…
Read More
Infection risk up in month after CAR T-cell immunotherapy
(HealthDay)—For children and young adults receiving CD19 chimeric antigen receptor (CAR) T-cell infusion (CTI), infection rates increase in the first month after treatment and then decrease, according to a study published in the May issue of Open Forum Infectious Diseases….
Read More